WARNING: We do not support Internet Explorer. It is not secure and will not work correctly. Please come back using a newer web browser.

Michael J. Loeffelholz, Director, CLSI

Michael J. Loeffelholz, PhD, D(ABMM)

Director, CLSI

Vice President, Scientific Affairs at Cepheid

Michael J. Loeffelholz, PhD, D(ABMM) is Vice President, Scientific Affairs at Cepheid, and Adjunct Professor of Pathology at the University of Texas Medical Branch (UTMB), Galveston. He received a PhD in microbiology from Ohio University in Athens, OH in 1987. After completing a postdoctoral fellowship in medical and public health microbiology at the University of Rochester in 1990, he was a Senior Scientist at Roche Molecular Systems from 1990-1995. From 1995-2008 Dr. Loeffelholz held leadership positions in public health laboratories and private reference laboratories. From 2008-2018 he held the rank of Associate Professor, then Full Professor, with tenure, in the Department of Pathology at University of Texas Medical Branch, and Medical Director of the Clinical Microbiology Laboratory. Dr. Loeffelholz joined Cepheid in 2018. He served as a member of the Board of Scientific Counselors to the Centers for Disease Control and Prevention (CDC) Deputy Director of Infectious Diseases from 2015 to 2022. Dr. Loeffelholz previously served as editor of the Journal of Clinical Microbiology. He is currently a member of the Clinical and Laboratory Standards Institute (CLSI) Expert Panel on Point-of-Care-Testing. He has authored over 100 research and review papers and book chapters.